SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
463spot on as they say here..As we deal with MS up close and directly, I agree withmopgcw-4/5/2008
462This seems like a good time and place to note the limitations of animal models ituck-4/4/2008
461ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Mmopgcw-4/4/2008
460ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patmopgcw-3/31/2008
459and another analyst raises his target price... (almost 2 weeks ago). Acadia PhIan@SI-3/21/2008
458>>ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter tuck-3/5/2008
457citi: ACADIA Pharmaceuticals Inc (ACAD) Revising Pimavanserin Timeline; Reducinmopgcw-2/2/2008
456>>it has completed enrollment in its Phase IIb clinical trial with ACP-104tuck-1/14/2008
455ACADIA Pharmaceuticals Announces Completion of Enrollment of ACP-104 Phase IIb Ctnsaf-1/14/2008
454J Steroid Biochem Mol Biol. 2007 Nov 22 [Epub ahead of print] Pharmacological cscaram(o)uche-1/6/2008
453Here is the link to the investor's day presentation: library.corporate-ir.nBiotech Jim-12/18/2007
452j. birchenough, lehman December 17, 2007 Acadia Pharmaceuticals (ACAD - US$ 12.software salesperson-12/18/2007
451citi: ACADIA Pharmaceuticals Inc (ACAD) Acadia Provides Update; ACP Phase II datmopgcw-12/18/2007
450ACADIA Pharmaceuticals Announces Completion of Enrollment of ACP-104 Phase IIb Cmopgcw-12/14/2007
449Answering my own Q, I should have looked first... ++++++++++++++++++++ ACADIA Ian@SI-12/12/2007
448Anyone see what JMP had to say today? ACADIA Pharmaceuticals ACAD Upgraded by Ian@SI-12/12/2007
447ACADIA Pharmaceuticals Reports Third Quarter 2007 Financial Results Monday Novemmopgcw-11/7/2007
446Hard to find a reason to still be holding this stock if their lead drug lacks a Bio-Newbie-11/6/2007
44509:16 am ACADIA Pharmaceuticals: Brean Murray downgrades Hold to Sell . Target $Ian@SI-11/6/2007
444Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Cascaram(o)uche-10/30/2007
443Am J Physiol Regul Integr Comp Physiol. 2007 Oct 24; [Epub ahead of print] A nescaram(o)uche-10/30/2007
442Parking: "CONSTITUTIVELY ACTIVE MUTANTS OF THE HISTAMINE H1 RECEPTOR SUGGEtuck-10/26/2007
441Citi: ACADIA Pharmaceuticals Inc (ACAD) Initiationmopgcw-10/3/2007
440[Clozapine Treatment of Childhood-Onset Schizophrenia] >>J Am Acad Child tuck-9/25/2007
439ACADIA Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Indexsim1-9/25/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News